Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer

BACKGROUND: CDH13 is a novel tumor suppressor gene often inactivated by aberrant promoter methylation in human cancers. Previous studies have shown that CDH13 methylation correlated with advanced disease and poor prognosis in non-muscle invasive bladder cancer (NMIBC). The aim of the current study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Li, Xie, Pei-Gen, Ma, Jian-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162450/
https://www.ncbi.nlm.nih.gov/pubmed/25196672
http://dx.doi.org/10.12659/MSM.892130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162450/
https://www.ncbi.nlm.nih.gov/pubmed/25196672
http://dx.doi.org/10.12659/MSM.892130

Ejemplares similares